GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 84 filers reported holding GENERATION BIO CO in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,906,257 | -33.9% | 502,970 | -4.1% | 0.00% | – |
| Q2 2023 | $2,883,222 | +30.5% | 524,222 | +2.0% | 0.00% | – |
| Q1 2023 | $2,209,314 | +14.3% | 513,794 | +4.4% | 0.00% | – |
| Q4 2022 | $1,933,464 | -25.2% | 491,976 | +1.0% | 0.00% | – |
| Q3 2022 | $2,585,000 | +93.3% | 486,884 | +138.9% | 0.00% | – |
| Q2 2022 | $1,337,000 | -14.6% | 203,817 | -4.5% | 0.00% | – |
| Q1 2022 | $1,566,000 | -9.4% | 213,349 | -12.6% | 0.00% | – |
| Q4 2021 | $1,728,000 | -70.9% | 244,151 | +3.1% | 0.00% | -100.0% |
| Q3 2021 | $5,937,000 | -13.2% | 236,796 | -6.9% | 0.00% | 0.0% |
| Q2 2021 | $6,841,000 | +37905.6% | 254,308 | +40459.5% | 0.00% | – |
| Q1 2021 | $18,000 | -93.0% | 627 | -93.1% | 0.00% | – |
| Q4 2020 | $257,000 | +335.6% | 9,070 | +373.4% | 0.00% | – |
| Q3 2020 | $59,000 | – | 1,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |